C4 Therapeutics (CCCC) Shares Issued (2019 - 2026)
C4 Therapeutics' quarterly Shares Issued came in at $605000.0 in Q1 2026, up 465.42% quarter-over-quarter from $107000.0 in Q3 2025.
C4 Therapeutics has reported Shares Issued for 8 years, with the latest figure at $605000.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $605000.0; the trailing twelve-month figure through Mar 2026 stood at $712000.0 (down 99.14% YoY), and the FY2025 full-year result was $107000.0, down 86.25% from the prior year.
- Shares Issued for Q1 2026 stood at $605000.0, up from $107000.0 in the prior quarter.
- The five-year high for Shares Issued was $82.3 million in Q4 2024, with the low at $2000.0 in Q2 2023.
- Average Shares Issued over 5 years is $7.0 million, with a median of $173000.0 recorded in 2022.
- Year-over-year, Shares Issued slumped 99.23% in 2023 and soared 6650.0% in 2024.
- Tracing CCCC's Shares Issued over 5 years: stood at $47000.0 in 2022, then tumbled by 95.74% to $2000.0 in 2023, then surged by 4114900.0% to $82.3 million in 2024, then plunged by 99.87% to $107000.0 in 2025, then soared by 465.42% to $605000.0 in 2026.
- The last three Shares Issued figures came in at $605000.0 (Q1 2026), $107000.0 (Q3 2025), and $82.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | 605,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 605,000.00 |
| Mar 31, 2026 | 605,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Dec 31, 2024 | 82.30 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 519,000.00 |
| Mar 31, 2024 | 519,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Sep 30, 2022 | 211,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 260,000.00 |
| Mar 31, 2022 | 260,000.00 |
| Dec 31, 2021 | 752,000.00 |
| Dec 31, 2021 | 752,000.00 |
| Sep 30, 2021 | 873,000.00 |
| Sep 30, 2021 | 873,000.00 |
| Jun 30, 2021 | 539,000.00 |
| Jun 30, 2021 | 539,000.00 |
| Mar 31, 2021 | 166,000.00 |
| Mar 31, 2021 | 166,000.00 |
| Dec 31, 2020 | 123,000.00 |
| Dec 31, 2020 | 123,000.00 |
| Sep 30, 2020 | 532,000.00 |
| Sep 30, 2020 | 532,000.00 |
| Jun 30, 2020 | 76,000.00 |
| Jun 30, 2020 | 76,000.00 |
| Mar 31, 2020 | 156,000.00 |
| Mar 31, 2020 | 156,000.00 |
| Dec 31, 2019 | 68,000.00 |
| Dec 31, 2019 | 68,000.00 |